David Chien has over 30 years of experience in the field of medical equipment, focusing primarily on corporate operations and sales and marketing. Chien is currently Chairman, President and CEO of OrbusNeich. He is devoted to the field of interventional cardiology and is the Vice Chairman of the Chien Foundation, a charitable organization with the vision of contributing to, and improving, the practice of cardiovascular medicine for physicians in the Asia-Pacific region. Apart from his interest in the medical equipment frontier, he also has 20 years of experience in real estate property investment, development and management in both Hong Kong and China. Until 2014 he held a position as Director of the Board of a listed Hong Kong company. He was responsible for organizing and managing the operations of the real estate property division of that company. Chien holds a BA in Business Administration from York University, Ontario, Canada.
Robert Cottone oversees the global creation, construction, filing and prosecution of all OrbusNeich patents, copyrights and trademarks. He is the named inventor of 31 issued U.S. patents and 56 U.S. patent applications, along with all of their corresponding international patent filings. Robert is instrumental in the concept, design and development of all stent, stent coating and advanced catheter construction programs, as well as provides leadership and technical expertise to ensure OrbusNeich’s products meet clinical and market requirements. Robert is the co-founder of Orbus Medical Technologies, the predecessor of OrbusNeich Medical, prior to which he helped manage the development, engineering, and manufacturing of several key product programs at Cordis Corporation including diagnostic catheters, endomyocardial biopsy forceps, and peripheral vascular stents. Robert has a Bachelor of Science in Industrial Engineering from Florida International University.
Alain Khair joined OrbusNeich in 2008 and has over 15 years of sales and marketing experience in the medical device industry. Prior to his current capacity, Alain has held several roles within the company including Regional Product Manager for business development in Canada, Eastern and Northern Europe, as well as Sales Director for South Europe and the Middle East. Before joining OrbusNeich, Alain worked for 7 years at Abbott Vascular involving coronary devices, vessel closures and endovascular sectors across EMEA. Alain resides in the United Kingdom and received his MBA degree in Marketing from Leicester University.
Takeshi Ohba has over 24 years of medical device experience and has served as the President of OrbusNeich Medical KK since 2002. Prior to joining, he worked at TUV Rheinland Japan as General Manager, at Jansen Pharmaceutical Japan (a Johnson & Johnson company) as a director in the sales promotion department and at Johnson & Johnson Medical K.K. (Cordis Cardiology) as a director of the marketing department. He graduated from Keio University, Tokyo and holds a Marketing degree from the Waseda University Business School.
Jason Chen joined OrbusNeich in 2017 and is responsible for overseeing the Group’s financial and accounting operations, human resources, IT and internal controls, and provides financial and business advice to the Board and senior management of the Group. He has 17 years of experience in auditing, accounting and corporate finance. Jason worked at PricewaterhouseCoopers for 13 years in the assurance practice and his last position was a senior manager when he left the firm. Before joining our Group, Jason worked in corporate finance in the property development and investment sector in the PRC. Jason graduated from the Chinese University of Hong Kong with a first-class honours degree of Bachelor of Business Administration and is a member of the American Institute of Certified Public Accountants and a member of the Hong Kong Institute of Certified Public Accountants.
Stephen Rowland joined OrbusNeich after a 14 year tenure at Cordis, where he was Vice President of Research and Development. Rowland was also Vice President and General Manager of Cordis Endovascular Systems, a separate business unit of Cordis focused on instrumentation to treat neurovascular diseases. He was responsible for all aspects of this start-up business including sales, marketing, development, strategic planning, and administration. His other experiences at Cordis included major contributions to advanced research and development across a variety of Cordis product initiatives. He is the inventor of nine issued U.S. patents, two published patent applications, and several other pending applications. Rowland holds a BS in Biology from West Virginia Wesleyan College and a PhD in Bio-engineering from the University of Utah.
Jim Clossick's background includes over 30 years of medical device experience. He specializes in international regulatory affairs, design control, process validation engineering, design of experiments, failure mode and effects analysis, customer requirements analysis, and quality functional deployment (QFD).Clossick provides leadership for seeking regulatory approvals for cardiovascular devices, including combination products. He holds two U.S. patents for device design. Clossick is a certified quality engineer, a certified Six Sigma Black Belt, and a certified QFD facilitator. In addition to his BS degree in Mechanical Engineering from the Missouri University of Science and Technology-Rolla, he has undertaken additional studies in Biomedical Engineering.
Hwei Davies joined OrbusNeich in 2019. She has over 19 years of experience as a lawyer and compliance specialist with both international firms and in-house. Prior to joining OrbusNeich, Hwei worked in the medical devices, high-tech manufacturing and hospitality sectors, and before that was a corporate lawyer in private practice for more than 12 years, advising on transactions and investments in the UK and across the APAC region. Hwei is a graduate of the University of Cambridge (Trinity College) and is admitted as a solicitor in England and Wales and Hong Kong.